Caerus Us 1
UEI: RLHVUTFVW2X8
• CAGE: 9K0B4
Overview
Awardee Type
Parent
Company Description
Citeline is the leading provider of drug, device, company, clinical trial and market intelligence in the pharmaceutical and medtech markets.
Name
Caerus Us 1
Website
Headquarters
New York, NY
United States
United States
Most Recent Award
March 19, 2026
Calculating
Federal contract recipient
CAERUS US 1 INC.
(UEI RLHVUTFVW2X8, CAGE 9K0B4)
is headquartered in New York NY.
Its primary registered NAICS is 513120 Periodical Publishers.
The corporation
was founded in June 2022 and
federally registered in
February 2023.
Federal Award Analysis
Caerus Us 1 federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CAERUS US 1 INC.
UEI
RLHVUTFVW2X8
CAGE Code
9K0B4
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
June 1, 2022
Initial Registration
Feb. 28, 2023
Last Registration
July 10, 2025
Registration Activation
July 10, 2025
Registration Expiration
July 10, 2026
Fiscal Year End
December 31
Reported Entity Types
Foreign Owned
For Profit Organization
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Caerus Us 1
Contract Awards
Caerus Us 1 prime contract awards
Subcontract Awards
Caerus Us 1 subcontract awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Caerus Us 1